prostate cancer

Dendreon's Provenge: Early Stage Use

Dendreon's Provenge: Early Stage Use

Seeking Alpha

Decision Date for Medivation Drug

Decision Date for Medivation Drug

Yahoo/Zacks

Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA

Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA

Yahoo/MarketWire

Submitted by moderatorj on Tue, 07/24/2012 - 20:47

Prostate cancer: Intuitive Surgical CEO Guthart on testing and "watchful waiting"

Prostate cancer: Intuitive Surgical CEO Guthart on testing and "watchful waiting"

Mass Device

Medivation and Astellas Pharma's NDA for enzalutamide accepted by FDA

Medivation and Astellas Pharma's NDA for enzalutamide accepted by FDA

Yahoo/Fly on the Wall

Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A

Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A

Bloomberg

Johnson & Johnson Widens Scope With Zytiga

Johnson & Johnson Widens Scope With Zytiga

Motley Fool

Johnson & Johnson files for approval of prostate cancer pill Zytiga earlier in treatment

Johnson & Johnson files for approval of prostate cancer pill Zytiga earlier in treatment

Yahoo/AP

ASCO Data Suggest Dendreon's Provenge Should Go First

ASCO Data Suggest Dendreon's Provenge Should Go First

Seeking Alpha

Provenge Has A Bigger Market Than You Think

Provenge Has A Bigger Market Than You Think

Seeking Alpha